Harmony Biosciences Holdings (HRMY) Gross Margin Growth (3y) (2023 - 2026)

Harmony Biosciences Holdings (HRMY) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Harmony Biosciences Holdings 2.07 Bn 1.55 Bn 170.88 Mn -322.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -322.00
Dec 31, 2025 -716.00
Sep 30, 2025 -532.00
Jun 30, 2025 -135.00
Mar 31, 2025 -7.00
Dec 31, 2024 -750.00
Sep 30, 2024 -490.00
Jun 30, 2024 -141.00
Mar 31, 2024 -33.00
Dec 31, 2023 -800.00
Sep 30, 2023 -285.00
Jun 30, 2023 -165.00
Mar 31, 2023 7.00